Adverse health effects linked to contaminated food material: A case study of pharmaceutical drug adulteration in food products and concise regulatory lookup

<strong>Background:</strong> This case study investigates the adverse health effects associated with pharmaceutical drug contamination in food products, emphasising the importance of food safety. <strong>Case presentation:</strong> An office worker presented with progressive symptoms, including persistent stomach pain, fatigue, and a notable decrease in body temperature after consuming a specific brand of food material over three weeks. Diagnostic evaluations revealed mild hepatic and renal stress alongside hypothermia. <strong>Methods:</strong> Laboratory analysis identified trace amounts of a pharmaceutical drug in the consumed food materials using UV-visible spectroscopy. Confirmatory tests, including ferric chloride and potassium dichromate reactions, corroborated the presence of active pharmaceutical ingredients. <strong>Results:</strong> The analysis indicated significant contamination, correlating with the symptomatic adverse effects observed, such as hepatic and renal stress and hypothermia. <strong>Conclusion:</strong> This study highlights the significant health risks posed by pharmaceutical adulteration in food products, whether through accidental contamination, deliberate adulteration, or environmental factors. It shows the critical need for stringent regulatory oversight and rigorous testing protocols to prevent the introduction of pharmaceutical contaminants into the food supply. The findings advocate for a comprehensive review of food safety standards and practices, emphasising robust detection methods and regulatory measures to safeguard public health against the dangers of active medication adulteration.